The Washington Manual Hematology and Oncology Subspecialty Consult

Concise, portable, and user-friendly, <B>The Washington Manual Hematology and Oncology Subspecialty Consult, 5th Edition</B>, provides quick access to the essential information needed to evaluate a patient on a hematology-oncology subspecialty consult service. Edited by Drs. Brian A. Van Tine and Meagan A. Jacoby, this best-selling manual offers state-of-the-art content, including coverage of new therapies such as CAR T-cell therapy, new anti-cancer drugs, and new biomarkers and therapeutic targets. Ideal for fellows, residents, and medical students rotating on hematology and oncology subspecialty services, the manual is also useful as a first-line resource for advanced practice providers, general internal medicine physicians, Hem/ONC fellows, and other primary care providers. <ul><li> Thoroughly revised to include <B>new therapies</B> such as PD-1 inhibitors for Hodgkin lymphoma, <B>CAR T-cell therapy</B> in NHL and multiple myeloma, gene therapy for sickle cell disease, CAR T-cell therapies and management of CRS and neurotoxicity, and more </li><li> It presents clinically oriented information like symptoms, signs, and problems in a <B>quick-reference, bulleted list format</B> for easy, everyday reference </li><li> Shares the knowledge and experience of a <B>new co-editor</B> of the Hematology section, Dr. Meagan Jacoby </li><li> Provides <B>updated references</B> for additional information on key topics </li><li> Written by fellows and  faculty from the Washington University School of Medicine in St. Louis </li></ul> The Washington Manual® is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by WoltersKluwer Health under license from Washington University. <P><I>Enrich your eBook reading experience</I></P><ul><li><B>Read directly on your preferred device(s),</B><B></B>such as computer, tablet, or smartphone. </li><li><B>Easily convert to audiobook,</B><B></B>powering your content with natural language text-to-speech. </li></ul>